Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein (Q83294448)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Vaccine potential of influenza vectors expressing Mycobacterium tuberculosis ESAT-6 protein (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

Mycobacterium tuberculosis

20 January 2020

main subject

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Boris Ferko

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Julia Romanova

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Sereinig S

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Zabolotnyh NV

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kittel C

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Vinogradova TI

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Katinger H

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Kiselev OI

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Egorov A

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

86

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

3-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

236-246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

Generation of influenza A viruses entirely from cloned cDNAs

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Development of novel influenza virus vaccines and vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Cold-adapted live attenuated influenza vaccines developed in Russia: can they contribute to meeting the needs for influenza control in other countries?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Safety, immunogenicity and efficacy of intranasal, live attenuated influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Rescue of influenza virus expressing GFP from the NS1 reading frame

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Amplification, expression, and packaging of foreign gene by influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Hyperattenuated recombinant influenza A virus nonstructural-protein-encoding vectors induce human immunodeficiency virus type 1 Nef-specific systemic and mucosal immune responses in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Intranasal inoculation of a recombinant influenza virus containing exogenous nucleotides in the NS segment induces mucosal immune response against the exogenous gene product in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Generation of recombinant influenza virus using baculovirus delivery vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Single intranasal mucosal Mycobacterium bovis BCG vaccination confers improved protection compared to subcutaneous vaccination against pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Intranasal BCG vaccination protects BALB/c mice against virulent Mycobacterium bovis and accelerates production of IFN-gamma in their lungs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Single mucosal, but not parenteral, immunization with recombinant adenoviral-based vaccine provides potent protection from pulmonary tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

ESAT-6 proteins: protective antigens and virulence factors?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Genetic vaccination against tuberculosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Improved immunogenicity of a tuberculosis DNA vaccine encoding ESAT6 by DNA priming and protein boosting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Virulence, immunogenicity, and protective efficacy of two recombinant Mycobacterium bovis bacillus Calmette-Guérin strains expressing the antigen ESAT-6 from Mycobacterium tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Enhanced immunogenicity and protective efficacy against Mycobacterium tuberculosis of bacille Calmette-Guérin vaccine using mucosal administration and boosting with a recombinant modified vaccinia virus Ankara

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Influenza A mutant viruses with altered NS1 protein function provoke caspase-1 activation in primary human macrophages, resulting in fast apoptosis and release of high levels of interleukins 1beta and 18

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

IL-4 in tuberculosis: implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Immunology of tuberculosis and implications in vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

Expression of a foreign protein by influenza A virus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TUBE.2006.01.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TUBE.2006.01.010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16677861%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference